Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Common Equity (2020 - 2025)

Historic Common Equity for Molecular Partners Ag (MOLN) over the last 6 years, with Q3 2025 value amounting to $5046.6.

  • Molecular Partners Ag's Common Equity rose 1916.89% to $5046.6 in Q3 2025 from the same period last year, while for Sep 2025 it was $5046.6, marking a year-over-year increase of 1916.89%. This contributed to the annual value of $4587.7 for FY2024, which is 9999.77% down from last year.
  • Latest data reveals that Molecular Partners Ag reported Common Equity of $5046.6 as of Q3 2025, which was up 1916.89% from $4876.3 recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Common Equity ranged from a high of $198.9 million in Q4 2023 and a low of $3500.7 during Q1 2022
  • Moreover, its 5-year median value for Common Equity was $4548.7 (2025), whereas its average is $20.4 million.
  • Per our database at Business Quant, Molecular Partners Ag's Common Equity soared by 531569045.53% in 2023 and then tumbled by 9999.77% in 2024.
  • Molecular Partners Ag's Common Equity (Quarter) stood at $116.4 million in 2021, then crashed by 100.0% to $3741.0 in 2022, then surged by 5315690.46% to $198.9 million in 2023, then plummeted by 100.0% to $4607.2 in 2024, then grew by 9.54% to $5046.6 in 2025.
  • Its last three reported values are $5046.6 in Q3 2025, $4876.3 for Q2 2025, and $4490.2 during Q1 2025.